STLN
Starling Oncology Inc.
STLN | NASDAQ
$6.53
-$0.12 (-1.80%)
At close: Oct 30, 2026, 3:59 PM ET
$6.53
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:24 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 |
|---|---|---|---|---|
Cash & Equivalents | 41.09M | 30.28M | 33.57M | 27.66M |
Short-Term Investments | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 657K | 620K | 606K | 586K |
Receivables | 66.71M | 59.45M | 59.32M | 59.98M |
Inventory | 20.01M | 24.29M | 16.88M | 18.88M |
Other Current Assets | 1.18M | 2.84M | 2.99M | 3.57M |
Total Current Assets | 128.99M | 116.86M | 112.75M | 110.09M |
Property-Plant & Equipment | 31.77M | 33.22M | 33.06M | 33.98M |
Goodwill & Intangibles | 16.82M | 17.53M | 18.25M | 18.96M |
Total Long-Term Assets | 49.24M | 51.37M | 51.91M | 53.53M |
Total Assets | 178.23M | 168.23M | 164.66M | 163.62M |
Account Payables | 60.28M | 47.65M | 43.17M | 35.63M |
Deferred Revenue | 2.16M | 2.04M | 2.28M | 4.9M |
Short-Term Debt | n/a | n/a | n/a | n/a |
Other Current Liabilities | 12.2M | 12.48M | 13.15M | 15.15M |
Total Current Liabilities | 94.94M | 79.35M | 70.96M | 65.58M |
Long-Term Debt | 79.87M | 78.61M | 77.4M | 76.2M |
Other Long-Term Liabilities | 10.96M | 7.71M | 12.88M | 13.92M |
Total Long-Term Liabilities | 108.21M | 105.16M | 109.41M | 110.31M |
Total Liabilities | 203.15M | 184.52M | 180.38M | 175.89M |
Total Debt | 104.48M | 104.86M | 103.69M | 103.55M |
Book Value | -24.91M | -16.29M | -15.72M | -12.27M |
Book Value Per Share | -0.24 | -0.16 | -0.15 | -0.13 |
Common Stock | 10K | 10K | 10K | 10K |
Retained Earnings | -283.7M | -273.91M | -271.42M | -263.91M |
Comprehensive Income | n/a | n/a | n/a | n/a |
Shareholders Equity | -24.91M | -16.29M | -15.72M | -12.27M |
Total Investments | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove STLN